summary
Introduced
01/16/2026
01/16/2026
In Committee
01/20/2026
01/20/2026
Crossed Over
Passed
Dead
Introduced Session
104th General Assembly
Bill Summary
Creates the Illinois Affordable Drug Manufacturing Act. Provides that the Department of Human Services shall enter into partnerships with drug companies or manufactures to: (i) increase competition, lower prices, and address shortages in the market for generic prescription drugs; (ii) reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers; and (iii) increase patient access to affordable drugs. Provides that such partnerships shall be made with the intent to ensure the wide availability of generic prescription drugs to public and private purchasers, providers and suppliers, and pharmacies as appropriate. Requires that such drugs must be produced or distributed by a drug company or generic drug manufacturer that is registered with the United States Food and Drug Administration. Sets forth price setting criteria and a list of the most common generic prescription drugs that are to be produced and distributed through the partnerships. Requires the Department to consult with other State agencies, licensed health care service plans, health insurers, hospitals, and pharmacy benefit managers in maintaining the list of generic prescription drugs. Contains provisions concerning minimum drug procurement thresholds; reporting requirements; and other matters. Makes implementation of the Act subject to appropriation. Effective immediately, except that certain provisions take effect on January 1, 2029.
AI Summary
This bill, titled the Illinois Affordable Drug Manufacturing Act, directs the Department of Human Services (DHS) to establish partnerships with drug companies and manufacturers to increase competition, lower prices, and address shortages of generic prescription drugs, ultimately making them more accessible and affordable for patients and purchasers. The DHS will work with registered drug companies to produce and distribute these medications, with a focus on a prioritized list of the 100 most common generic drugs, which will be updated every five years. The bill outlines criteria for setting drug prices, considering factors like manufacturing costs and user fees, and mandates transparent pricing without hidden rebates. To inform these efforts, DHS will consult with various state agencies, health insurers, hospitals, and pharmacy benefit managers (companies that manage prescription drug benefits for health plans). The implementation of this act is contingent on state funding through appropriations, and while most provisions take effect immediately, the section detailing drug acquisition, distribution, and price setting will become active on January 1, 2029.
Sponsors (1)
Last Action
Referred to Rules Committee (on 01/20/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...